US · Healthcare

SymBio Pharmaceuticals Limited (SYMQY)

Drug Manufacturers - Specialty & Generic

SymBio Pharmaceuticals Limited (SYMQY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SYMQY

P/E ratio

18.00

SymBio Pharmaceuticals Limited (SYMQY) — FAQ

What is SYMQY's P/E ratio?

The price-to-earnings (P/E) ratio for SymBio Pharmaceuticals Limited (SYMQY) is 18.00 (data as of 2026-05-23).

Does SymBio Pharmaceuticals Limited pay a dividend?

Dividend yield is not available in the current snapshot for SymBio Pharmaceuticals Limited (SYMQY). Check the MyAverix Finance app for the latest dividend data.

What sector is SymBio Pharmaceuticals Limited in?

SymBio Pharmaceuticals Limited (SYMQY) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is SYMQY listed on?

SYMQY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)